CL2008000078A1 -
COMPOUNDS DERIVED FROM INDOL; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT A VIRAL INFECTION AND VIRAL HEPATITIS.
- Google Patents
COMPOUNDS DERIVED FROM INDOL; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT A VIRAL INFECTION AND VIRAL HEPATITIS.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/653,450external-prioritypatent/US7781478B2/en
Application filed by Ptc Therapeutics IncfiledCriticalPtc Therapeutics Inc
Publication of CL2008000078A1publicationCriticalpatent/CL2008000078A1/en
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
CL200800078A2007-01-132008-01-11
COMPOUNDS DERIVED FROM INDOL; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT A VIRAL INFECTION AND VIRAL HEPATITIS.
CL2008000078A1
(en)
COMPOUNDS DERIVED FROM INDOL WITH UNITED RING IN POSITIONS 4,5; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND TO TREAT A VIRAL INFECTION.
Benzimidazole-imidazole derivative compounds, hepatitis c virus (hcv) inhibitors; pharmaceutical composition comprising them; pharmaceutical combination; use in the prevention or treatment of hcv infection.
COMPOUNDS DERIVED FROM INDOL WITH A UNITED RING IN POSITIONS 4 AND 5; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO PREPARE A MEDICINAL PRODUCT TO TREAT A VIRAL INFECTION.
COMPOUNDS DERIVED FROM INDOL WITH A UNITED RING IN POSITIONS 5 AND 6; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO PREPARE A MEDICINAL PRODUCT TO TREAT A VIRAL INFECTION.
Compounds derived from biphenyl-pyrrolidinyl-imidazole; pharmaceutical composition comprising them; its use in the treatment of an hcv viral infection.
Compounds derived from 3-phenylpyridin-2-one, viral RNA dependent rna polymerase inhibitors; pharmaceutical composition comprising said compounds; and its use for the treatment of a disease caused by the hepatitis c virus.
COMPOUNDS DERIVED FROM MACROCICLES, INHIBITORS OF THE HEPATITIS C VIRUS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF HEPATITIS C.
Compounds derived from tripeptides containing nitrogen heterocycles; pharmaceutical composition comprising said compounds; and use to treat a hepatitis c or hiv infection.
COMPOUNDS DERIVED FROM SULFUR, INHIBITORS OF THE SERINA PROTEASA NS3 OF THE VIRUS OF HEPATITIS C; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF ASSOCIATED DISORDERS TO HCV PROTEASE.
COMPOUNDS DERIVED FROM OXAZOLIDINONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO PREPARE A MEDICINAL PRODUCT TO TREAT A BACTERIAL INFECTION.
COMPOUNDS DERIVED FROM FTALAZINONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT VASCULAR DISEASES, SEPTIC SHOCK, ISCHEMICAL INJURIES, NEUROTOXICITY, HEMORRAGICAL SHOCK, VIRAL INFECTIONS, AMONG OTHERS.
COMPOUNDS DERIVED FROM OXAZOLIDINONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO PREPARE A MEDICINAL PRODUCT TO TREAT A BACTERIAL INFECTION.